SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the June 2024 quarter moved down -35.44% to Rs. 2220.90 millions as compared to Rs. 3440.30 millions during the year ago period.The Net Profit of the company slipped to Rs. 650.80 millions from Rs. 1243.00 millions, a decline of -47.64% on QoQ basis.The company reported a degrowth in operating Profit to 1009.90 millions from 1807.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2220.90 3440.30 -35.44 2220.90 3440.30 -35.44 10249.93 13300.80 -22.94
Other Income 179.50 100.60 78.43 179.50 100.60 78.43 550.93 445.52 23.66
PBIDT 1009.90 1807.30 -44.12 1009.90 1807.30 -44.12 4649.93 6352.40 -26.80
Interest 16.00 18.60 -13.98 16.00 18.60 -13.98 74.27 127.48 -41.74
PBDT 993.90 1788.70 -44.43 993.90 1788.70 -44.43 4575.66 6224.92 -26.49
Depreciation 120.00 112.20 6.95 120.00 112.20 6.95 487.92 430.99 13.21
PBT 873.90 1676.50 -47.87 873.90 1676.50 -47.87 4087.74 5793.93 -29.45
TAX 223.10 433.50 -48.54 223.10 433.50 -48.54 1039.59 1467.91 -29.18
Deferred Tax 23.00 20.40 12.75 23.00 20.40 12.75 65.92 43.38 51.96
PAT 650.80 1243.00 -47.64 650.80 1243.00 -47.64 3048.15 4326.02 -29.54
Equity 254.60 254.60 0.00 254.60 254.60 0.00 254.57 254.57 0.00
PBIDTM(%) 45.47 52.53 -13.44 45.47 52.53 -13.44 45.37 47.76 -5.01

Cohance Lifesciences Share Price

475.45 -3.20 (-0.67%)
12-May-2026 10:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1870.85
Dr. Reddys Lab 1276.85
Cipla 1298.80
Zydus Lifesciences 944.50
Lupin 2245.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×